These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 29127457)

  • 41. Functional and mechanistic roles of the human proton-coupled folate transporter transmembrane domain 6-7 linker.
    Wilson MR; Hou Z; Wilson LJ; Ye J; Matherly LH
    Biochem J; 2016 Oct; 473(20):3545-3562. PubMed ID: 27514717
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of folate receptor alpha (FRalpha) in the response of malignant pleural mesothelioma to pemetrexed-containing chemotherapy.
    Nutt JE; Razak AR; O'Toole K; Black F; Quinn AE; Calvert AH; Plummer ER; Lunec J
    Br J Cancer; 2010 Feb; 102(3):553-60. PubMed ID: 20051956
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development and validation of chemical features-based proton-coupled folate transporter/activity and reduced folate carrier/activity models (pharmacophores).
    Shah K; Raghavan S; Hou Z; Matherly LH; Gangjee A
    J Mol Graph Model; 2018 May; 81():125-133. PubMed ID: 29550744
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Concentrative Transport of Antifolates Mediated by the Proton-Coupled Folate Transporter (SLC46A1); Augmentation by a HEPES Buffer.
    Zhao R; Najmi M; Aluri S; Spray DC; Goldman ID
    Mol Pharmacol; 2018 Mar; 93(3):208-215. PubMed ID: 29326243
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional roles of the A335 and G338 residues of the proton-coupled folate transporter (PCFT-SLC46A1) mutated in hereditary folate malabsorption.
    Shin DS; Zhao R; Fiser A; Goldman DI
    Am J Physiol Cell Physiol; 2012 Oct; 303(8):C834-42. PubMed ID: 22843796
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The membrane transport and polyglutamation of pralatrexate: a new-generation dihydrofolate reductase inhibitor.
    Visentin M; Unal ES; Zhao R; Goldman ID
    Cancer Chemother Pharmacol; 2013 Sep; 72(3):597-606. PubMed ID: 23881211
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural basis for recognition and transport of folic acid in mammalian cells.
    Newstead S
    Curr Opin Struct Biol; 2022 Jun; 74():102353. PubMed ID: 35303537
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rodent intestinal folate transporters (SLC46A1): secondary structure, functional properties, and response to dietary folate restriction.
    Qiu A; Min SH; Jansen M; Malhotra U; Tsai E; Cabelof DC; Matherly LH; Zhao R; Akabas MH; Goldman ID
    Am J Physiol Cell Physiol; 2007 Nov; 293(5):C1669-78. PubMed ID: 17898134
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The monomeric state of the proton-coupled folate transporter represents the functional unit in the plasma membrane.
    Duddempudi PK; Nakashe P; Blanton MP; Jansen M
    FEBS J; 2013 Jun; 280(12):2900-15. PubMed ID: 23601781
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sustained inhibition of proton-coupled folate transporter by myricetin.
    Furumiya M; Yamashiro T; Inoue K; Nishijima C; Ohta K; Hayashi Y; Yuasa H
    Drug Metab Pharmacokinet; 2015 Apr; 30(2):154-9. PubMed ID: 25801697
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel 5-substituted pyrrolo[2,3-d]pyrimidines as dual inhibitors of glycinamide ribonucleotide formyltransferase and 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase and as potential antitumor agents.
    Wang Y; Mitchell-Ryan S; Raghavan S; George C; Orr S; Hou Z; Matherly LH; Gangjee A
    J Med Chem; 2015 Feb; 58(3):1479-93. PubMed ID: 25602637
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of the fourth transmembrane domain in proton-coupled folate transporter function as assessed by the substituted cysteine accessibility method.
    Shin DS; Zhao R; Fiser A; Goldman ID
    Am J Physiol Cell Physiol; 2013 Jun; 304(12):C1159-67. PubMed ID: 23552283
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Noncompetitive inhibition of proton-coupled folate transporter by myricetin.
    Furumiya M; Inoue K; Nishijima C; Yamashiro T; Inaoka E; Ohta K; Hayashi Y; Yuasa H
    Drug Metab Pharmacokinet; 2014; 29(4):312-6. PubMed ID: 24492671
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The functional roles of the His247 and His281 residues in folate and proton translocation mediated by the human proton-coupled folate transporter SLC46A1.
    Unal ES; Zhao R; Chang MH; Fiser A; Romero MF; Goldman ID
    J Biol Chem; 2009 Jun; 284(26):17846-57. PubMed ID: 19389703
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The proton-coupled folate transporter: physiological and pharmacological roles.
    Zhao R; Goldman ID
    Curr Opin Pharmacol; 2013 Dec; 13(6):875-80. PubMed ID: 24383099
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Site-specific contribution of proton-coupled folate transporter/haem carrier protein 1 in the intestinal absorption of methotrexate in rats.
    Yokooji T; Mori N; Murakami T
    J Pharm Pharmacol; 2009 Jul; 61(7):911-8. PubMed ID: 19589233
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pemetrexed disodium.
    Gibbs D; Jackman A
    Nat Rev Drug Discov; 2005 May; Suppl():S16-7. PubMed ID: 15962527
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypermethylation of the human proton-coupled folate transporter (SLC46A1) minimal transcriptional regulatory region in an antifolate-resistant HeLa cell line.
    Diop-Bove NK; Wu J; Zhao R; Locker J; Goldman ID
    Mol Cancer Ther; 2009 Aug; 8(8):2424-31. PubMed ID: 19671745
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Substitutions that lock and unlock the proton-coupled folate transporter (PCFT-SLC46A1) in an inward-open conformation.
    Aluri S; Zhao R; Lin K; Shin DS; Fiser A; Goldman ID
    J Biol Chem; 2019 May; 294(18):7245-7258. PubMed ID: 30858177
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pemetrexed and its emerging role in the treatment of thoracic malignancies.
    Scagliotti GV; Novello S
    Expert Opin Investig Drugs; 2003 May; 12(5):853-63. PubMed ID: 12720495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.